10.1016/j.celrep.2019.01.089
Summary pCT could theoretically be used to assess BBB integrity, but it is rarely performed
Cordycepin is currently in clinical trials (phase I/II) to treat leukemia (National Cancer Institute, 2011), and was found to activate AMPK (Wang et al., 2019)
Thornes proprietary Time-Sorb matrix is the most established sustained-release technology in the glutathione category
Chen M, Zhu J-Y, Mu W-J, Luo H-Y, Li Y, Li S, et al
BPC-157 Research Applications Common Laboratory Research Areas BPC-157 peptide research commonly involves: Cellular signaling Tissue pathway studies Endothelial research Angiogenesis investigation Peptide receptor activity Laboratory regenerative research Researchers continue studying peptide signaling pathways related to BPC-157 in controlled laboratory environments